These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33556121)

  • 1. Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.
    Chu S; Skidmore ZL; Kunisaki J; Walker JR; Griffith M; Griffith OL; Bryan JN
    PLoS One; 2021; 16(2):e0246443. PubMed ID: 33556121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 gene mutations in canine osteosarcoma.
    Kirpensteijn J; Kik M; Teske E; Rutteman GR
    Vet Surg; 2008 Jul; 37(5):454-60. PubMed ID: 18986312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of P16 expression in canine appendicular osteosarcoma.
    Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
    BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 gene mutations in osteosarcomas in the dog.
    van Leeuwen IS; Cornelisse CJ; Misdorp W; Goedegebuure SA; Kirpensteijn J; Rutteman GR
    Cancer Lett; 1997 Jan; 111(1-2):173-8. PubMed ID: 9022143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The animal-dependent risk factors in canine osteosarcomas.
    Sapierzyński R; Czopowicz M
    Pol J Vet Sci; 2017 Mar; 20(2):293-298. PubMed ID: 28865206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
    Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of the p53, Rb and MDM2 genes in canine osteosarcoma.
    Mendoza S; Konishi T; Dernell WS; Withrow SJ; Miller CW
    Anticancer Res; 1998; 18(6A):4449-53. PubMed ID: 9891508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating CXCR4 expression in canine appendicular osteosarcoma.
    Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
    J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog.
    Johnson AS; Couto CG; Weghorst CM
    Carcinogenesis; 1998 Jan; 19(1):213-7. PubMed ID: 9472714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.
    Ayers J; Milner RJ; Cortés-Hinojosa G; Riva A; Bechtel S; Sahay B; Cascio M; Lejeune A; Shiomitsu K; Souza C; Hernandez O; Salute M
    J Vet Diagn Invest; 2021 Mar; 33(2):261-278. PubMed ID: 33446089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
    Morello E; Martano M; Buracco P
    Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
    York D; Withers SS; Watson KD; Seo KW; Rebhun RB
    Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent and current clinical trials in canine appendicular osteosarcoma.
    Poon AC; Matsuyama A; Mutsaers AJ
    Can Vet J; 2020 Mar; 61(3):301-308. PubMed ID: 32165755
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
    Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
    Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
    Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine osteosarcoma genome sequencing identifies recurrent mutations in
    Gardner HL; Sivaprakasam K; Briones N; Zismann V; Perdigones N; Drenner K; Facista S; Richholt R; Liang W; Aldrich J; Trent JM; Shields PG; Robinson N; Johnson J; Lana S; Houghton P; Fenger J; Lorch G; Janeway KA; London CA; Hendricks WPD
    Commun Biol; 2019; 2():266. PubMed ID: 31341965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma.
    Das S; Idate R; Regan DP; Fowles JS; Lana SE; Thamm DH; Gustafson DL; Duval DL
    Commun Biol; 2021 Oct; 4(1):1178. PubMed ID: 34635775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.
    Levine RA; Fleischli MA
    Vet Pathol; 2000 Jan; 37(1):54-61. PubMed ID: 10643981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the biology and management of canine osteosarcoma.
    Chun R; de Lorimier LP
    Vet Clin North Am Small Anim Pract; 2003 May; 33(3):491-516, vi. PubMed ID: 12852233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.